Correlation Analysis
Bristol-Myers Squibb Co. vs Oracle Corp
BMY vs ORCL
-0.696
Strong inverse
When one moves up, the other tends to move down.
Bristol-Myers Squibb Co.
↗BMY
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Market cap 121.1B · 32,500 employees
Oracle Corp
↗ORCL
Oracle provides enterprise applications and infrastructure offerings through a variety of flexible IT deployment models, including on-premises, cloud-based, and hybrid. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system, which is commonly used by the world's largest companies for high-volume online transaction processing workloads. Besides databases, Oracle also sells enterprise resource planning platforms and cloud infrastructure that play an increasingly important role in large language model training and inferencing.
Market cap 418.6B
Time Series
Relative Performance
Who Moves First
BMY leads ORCL by 6 days
BMY tends to move before ORCL.
After testing 13 timing shifts, the strongest relationship was -0.704 (they moved in opposite directions).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
-0.591
9 periods · Return correlation when both series rose
Both Falling
-0.590
6 periods · Return correlation when both series fell
Diverging
-0.605
20 periods · Return correlation when series moved apart
R-Squared
48.4%
Share of variance in one series explained by the other.
Trend Agreement
52.7%
How often both series moved in the same direction period-to-period.
Overlap Quality
1,254
Deep shared window — 1,254 usable pairs.
Significance
p < 0.001
95% CI: [-0.723, -0.666]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
1,254 paired data points survived the daily window.
Raw input
1,254
1,254
Normalized
1,254
1,254
Prepared
1,254
1,254
Aligned
1,254
1,254
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
0
A: 0 / B: 0
Series A
Bristol-Myers Squibb Co.
BMY
Market cap 121.1B · 32,500 employees
Stock · 1,254 raw → 1,254 prepared
Series B
Oracle Corp
ORCL
Market cap 418.6B
Stock · 1,254 raw → 1,254 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
13
Estimated crossover points between normalized spreads.
Slope
-3.6782
Linear regression slope.
Intercept
345.3719
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
Saved 7 hours ago · ID: stock-bmy-vs-stock-orcl-daily